Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Alumis Presents Preclinical Data for Allosteric TYK2 Inhibitor A-005 at ACTRIMS
-
Euro Sun Mining Concludes Successful Meetings with Romanian Ministries and Issues Promissory Note
-
BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Dat
-
Refined Metals Corp. Announces Planned Name Change to Refined Energy Corp.
-
PainReform Provides Year-End Business Update
-
Praxis Precision Medicines to Participate in TD Cowen’s 44th Annual Health Care Conference
-
Company Statement
-
Immuneering Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
Blue World Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination
-
vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference
-
Aemetis to Review Fourth Quarter and Year End 2023 Financial Results on March 7, 2024
-
Fate Therapeutics to Present at Upcoming March Investor Conferences
-
Karat Packaging to Report 2023 Fourth Quarter and Full Year Financial Results and Host Conference Call on Thursday, March 14, 2024
-
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
-
Changes in the number of own shares held by Aktia Bank Plc
-
Recursion to Participate in Upcoming Investor Conferences
-
Alpha Cognition to Present at the Life Science Investor Forum March 7th
-
Vesting of Performance Share Units and delivery of ISS shares on 1 March 2024
-
Alliance Trust PLC - Total Voting Rights
-
Atlantica Reports 2023 Financial Results
-
Form 8.3 - [WINCANTON PLC] - 29 02 2024 - (CGAML)
-
Form 8.3 - [LXi REIT PLC] - 29 02 2024 - (CGWL)
-
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
-
Man Group PLC : Form 8.3 - Redrow Plc
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC] - 29 02 2024 - (CGWL)
-
Man Group PLC : Form 8.3 - Barratt Developments Plc
-
Man Group PLC : Form 8.3 - UK Commercial Property REIT Limited
-
Man Group PLC : Form 8.3 - Tritax Big Box REIT Plc
-
Oyster Consulting Hires Dan Garrett, Digital and Business Strategy Leader
-
Shenandoah Telecommunications Company to Sell its Towers for $310 Million
-
Li Auto Inc. Hosts 2024 Spring Launch Event
-
Fox River Provides Corporate Update for 2024
-
Sable Announces Preliminary Results from Cerro Negro Greenfields Project in San Juan Argentina
-
Boralex posts record net earnings of $115 million for 2023 and increases its financial flexibility, with nearly $550 million in available cash resources and authorized financing1 to support its growth
-
Highwoods Provides Leasing Update
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
-
BioXcel Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
-
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024
-
U.S. Navy Selects Mercury to Deliver Electronic Warfare Combat Training Subsystems
-
Inception Growth Acquisition Limited Announces Additional Contribution to Trust Account to Extend Business Combination Period
-
WOO X appoints ex-Credit Suisse lead as Chief Product Officer
-
The Macerich Company Announces Grant of Employment Inducement Award in Connection with Appointment of Jackson Hsieh as President and Chief Executive Officer
-
Bitfarms Earns 300 BTC in February 2024; Provides Update on Fleet Upgrade
-
ATHA Energy Announces Approval to List on TSXV and Receipt of Final Order for Arrangement With Latitude Uranium
-
Christina Lake Closes First Tranche of Non-Brokered Private Placement of Secured Convertible Notes
-
Solaris Announces Cooperation Agreement with Interprovincial Federation of Shuar Centers and the Alliance for Entrepreneurship and Innovation of Ecuador
-
Plug Highlights Year of Strategic Growth and Advancements in Accelerating the Green Hydrogen Economy
-
Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma
-
iTeos to Participate in Upcoming Investor Conferences
-
Immunocore to present at upcoming investor conferences
